|
End-of-day quote
Shenzhen S.E.
28/08/2026
|
5-day change | 1st Jan Change | ||
| 8.840 CNY | +1.61% |
|
+7.80% | +2.31% |
| Market Cap | 4.51B 671M 578M 542M 495M 932M 64.13B 935M 6.43B 2.51B 32.37B 2.52B 2.46B 107B | P/E 2024 |
65.6x | P/E 2025 | 89.6x |
|---|---|---|---|---|---|
| Enterprise Value | 4.04B 600M 517M 485M 442M 833M 57.32B 836M 5.75B 2.24B 28.94B 2.25B 2.2B 95.94B | EV / Sales 2024 |
3.66x | EV / Sales 2025 | 4.3x |
| Free-Float |
34.06% | Yield 2024 |
0.16% | Yield 2025 | 0.23% |
| 1 day | +1.61% | ||
| 1 week | +7.80% | ||
| Current month | +14.51% | ||
| 1 month | +14.66% | ||
| 3 months | +13.62% | ||
| 6 months | -2.32% | ||
| Current year | +2.31% |
| 1 week | 8.08 | 9.02 | |
| 1 month | 7.64 | 9.02 | |
| Current year | 6.63 | 11.02 | |
| 1 year | 6.63 | 11.02 | |
| 3 years | 5.84 | 11.85 | |
| 5 years | 5.84 | 15.17 | |
| 10 years | 5.84 | 15.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 62 | 05/04/2022 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 01/12/2022 |
Li Jun Wu
PRN | Corporate Officer/Principal | 52 | 31/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Wen Bo Su
CHM | Chairman | 60 | 07/05/2014 |
Ai Guo Shi
CHM | Chairman | 62 | 29/06/2017 |
Zhi Jun Liu
BRD | Director/Board Member | 54 | 11/04/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.61% | +7.80% | -2.86% | -18.00% | 671M | ||
| +0.02% | +1.36% | -13.16% | -6.82% | 13.26B | ||
| +0.53% | +2.99% | -31.39% | -57.20% | 4.99B | ||
| +0.27% | +1.59% | -5.32% | -1.35% | 4.66B | ||
| -0.43% | -1.64% | -1.22% | -30.41% | 4.02B | ||
| +0.08% | +3.06% | -20.99% | +4.99% | 3.59B | ||
| -0.67% | +2.71% | -2.98% | -5.08% | 3.43B | ||
| +0.47% | -0.53% | -9.87% | +6.74% | 3.31B | ||
| -2.19% | -2.26% | -22.25% | -14.00% | 2.38B | ||
| +0.74% | +2.97% | -26.78% | -13.38% | 1.72B | ||
| Average | +0.04% | +2.52% | -13.68% | -13.45% | 4.2B | |
| Weighted average by Cap. | -0.02% | +1.83% | -13.80% | -13.09% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 980M 146M 126M 118M 107M 202M 13.92B 203M 1.4B 545M 7.03B 547M 535M 23.31B | 916M 136M 117M 110M 100M 189M 13.01B 190M 1.3B 509M 6.57B 511M 500M 21.77B |
| Net income | 60.07M 8.93M 7.69M 7.21M 6.58M 12.4M 853M 12.44M 85.58M 33.39M 431M 33.52M 32.79M 1.43B | 49.21M 7.31M 6.3M 5.91M 5.39M 10.16M 699M 10.19M 70.1M 27.35M 353M 27.46M 26.86M 1.17B |
| Net Debt | -357M -53.08M -45.74M -42.88M -39.14M -73.74M -5.07B -73.98M -509M -198M -2.56B -199M -195M -8.49B | -479M -71.19M -61.35M -57.52M -52.51M -98.92M -6.8B -99.23M -682M -266M -3.43B -267M -261M -11.39B |
Employees
1,332
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | CN¥8.840 | +1.61% | 16,605,387 |
| 27/08/26 | CN¥8.700 | +1.16% | 10,136,900 |
| 26/08/26 | CN¥8.600 | +1.06% | 12,662,700 |
| 25/08/26 | CN¥8.510 | +4.03% | 13,282,300 |
| 24/08/26 | CN¥8.180 | -0.24% | 11,679,900 |
- Stock Market
- Stocks
- 002644 Stock
Select your edition
All financial news and data tailored to specific country editions
















